Contribution of risk factors to the development of adverse cardiovascular events in Kemerovo Oblast population: data from a prospective study

Aim. To assess the rate of a combined endpoint (fatal and non-fatal cardiovascular events) and the contribution of cardiovascular risk factors to its development in Kemerovo Oblast population.

Material and methods. A clinical and epidemiological prospective study was conducted in the Kemerovo Oblast at the Research Institute for Complex Issues of Cardiovascular Diseases. The first stage (20172019) was inclusion of respondents and examination (n=1600). Prospective stage (2020-2021) included re-examination after 3 years sical inactivity, and smoking. The composite endpoint (CEP) included fatal and non-fatal cardiovascular events.

Results. Individuals with CEP were characterized by higher cardiome obesity (OR=2,12, p=0,001), abdominal obesity (OR=2,65, p=0,001) and carbohydrate metabolism disorders (OR=1,88, p=0,001) were associated with the risk of CEP. Taking into account the significance criterion (Wald), the CEP probability over a 3-year period was determined by the following variables: age (Wald test 32,8), abdominal obesity (Wald criterion 19,3), hypercholesterolemia (Wald criterion 8,8) and obesity (Wald criterion 7,3).

Conclusion. The study results emphasized the role of regional factors in the risk of adverse cardiovascular events, justifying the need for similar studies in other Russian regions.

1. Balanova YuA, Shalnova SA, Kutsenko VA, et al. Contribution of hypertension and other risk factors to survival and mortality in the Russian population. Cardiovascular Therapy and Prevention. 2021;20(5):3003. (In Russ.) doi:10.15829/1728-8800-2021-3003.

2. Ettehad D, Emdin CA. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis. Lancet. 2016;10022(387):957-67. doi:10.1016/S01406736(15)01225-8.

3. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prediabetes: prevalence, associations with cardiovascular risk factors and contribution to survival in the Russian population. Cardiovascular Therapy and Prevention. 2024;23(5):4022. (In Russ.) doi:10.15829/1728-8800-2024-4022.

4. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 2015;131(4):e29-e39. doi:10.1161/CIR.0000000000000152.

5. Cholesterol Treatment Trialists' (CTT) Collaborators; Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581-90. doi:10.1016/S0140-6736(12)60367-5.

6. Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all-cause mortality and cardiovascular disease: Updated meta-analysis. BMJ. 2020;15;370:m2297. doi:10.1136/bmj.m2297.

7. Agienko AS, Strokolskaya IL, Heraskov VYu, et al. Epidemiology of cardiovascular risk factors and the medical care appealability. Complex Issues of Cardiovascular Diseases. 2022;11(4):79-89. (In Russ.) doi:10.17802/2306-1278-2022-11-4-79-89.

8. Gaziev TF, Mulerova TA, Bazdyrev ED. Associations between physical activity, infrastructure parameters of the area of residence, and modifiable cardiovascular risk factors. Arterial Hypertension. 2024;30(5):497-508. (In Russ.) doi:10.18705/1607-419X-20242468.

9. Maksimov SA, Fedorova NV, Tsygankova DP, et al. Associations between physical activity in adults and walkability of the Neighborhood. Human Ecology. 2020;7(4):33-41. (In Russ.) doi:10.33396/1728-0869-2020-4-33-41.

10. Lenth R, Lenth MR. Package "lsmeans". The American Statistician. 2018;34(4):216-21.

11. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2016;37:2315-81. doi:10.1093/eurheartj/EHW106.

12. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439-54. doi:10.1093/eurheartj/ehab309.

13. Filippov EV, Vorobyev AN, Dobrynina NV, et al. Adverse cardiovascular outcomes and their relationship with risk factors according to the prospective study MERIDIAN-RO. Russian Journal of Cardiology. 2019;(6):42-8. (In Russ.) doi:10.15829/15604071-2019-6-42-48.

14. Stryukova EV, Shcherbakova LV, Gafarov VV, et al. Risk of fatal and non-fatal cardiovascular events in men aged 25-44 in the city of Novosibirsk. Cohort study. Cardiovascular Therapy and Prevention. 2023;22(1):3393. (In Russ.) doi:10.15829/1728-8800-2023-3393.

15. The Global Cardiovascular Risk Consortium. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389:1273-85 doi:10.1056/NEJMoa2206916.

16. Akimova EV, Pushkarev GS, Gafarov VV, et al. Risk of cardiovascular death in relation to blood pressure levels in Tyumen men and women: results of a 12-year prospective study. Terapevticheskii Arkhiv. 2013;85(3):70-4. (In Russ.)

17. Dolgalev IV, Brazovskaya NG, Ivanova AYu, et al. Influence of arterial hypertension, smoking, and their combination on mortality (according to the results of a 27-year cohort prospective study of the unorganized population of Tomsk). Russian Journal of Cardiology. 2019;(1):32-7. (In Russ.) doi:10.15829/1560-4071-2019-1-32-37

18. Zhuang P, Wu F, Mao L, et al. Egg and cholesterol consumption andmortality from cardiovascular and different causes in the United States: A populationbased cohort study. PLoS Med. 2021;18(2):e1003508. doi:10.1371/journal.pmed.1003508.

19. Kuntsevich AK, Rymar OD, Mustafina SV, et al. Association of dietary cholesterol intake with the risk of fatal cardiovascular events in individuals with type 2 diabetes. Diabetes mellitus. 2023;26(4):318-27. (In Russ.) doi:10.14341/DM12940.

20. Cerhan JR, Moore SC, Jacobs EJ, et al. A Pooled Analysis of Waist Circumference and Mortality in 650,000 Adults. Mayo Clin Proc. 2014;89(3):335-45. doi:10.1016/j.mayocp.2013.11.011.

21. Polupanov AG, Mamatov AU, Kontsevaya AV, et al. Relationship of lipid metabolism disorders with the development of fatal and non-fatal cardiovascular events in residents of the Chui region of the Kyrgyz Republic of varying sex and ethnicity. Cardiovascular Therapy and Prevention. 2022;21(3):3082. (In Russ.) doi:10.15829/1728-8800-2022-3082.

22. The Global BMI Mortality Collaboration. Body-mass index and allcause mortality: individual participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388: 776-86. doi:10.1016/S0140-6736(16)30175-1.